Background The role of mineralocorticoid receptor antagonists (MRAs) in acute myocardial infarction (MI) remains controversial, with conflicting evidence from landmark trials. We aimed to assess the ...

An appropriate duration of dual antiplatelet therapy after percutaneous coronary intervention for acute myocardial infarction that has been treated with guideline-recommended complete ...

1. Magnetic resonance imaging (MRI) imaging in minor ischemic stroke patients reclassifies some cryptogenic stroke patients to small vessel occlusions. 2. Patients with MRI-defined cryptogenic embolic ...

Cardio-cerebral infarction (CCI) is a rare clinical syndrome characterized by the simultaneous or sequential occurrence of acute myocardial infarction (AMI) and acute ischemic stroke (AIS). Despite ...

Myocardial ischemia is a drop in blood flow to the heart. Myocardial infarction, or heart attack, occurs when death or damage occurs in the muscle tissue of the heart due to low blood supply. The ...

ABSTRACT: Background: A major cause of mortality and disability on a global scale is myocardial infarction (MI). These days, the most reliable way to detect and measure MI is via cardiovascular ...

After reading the article “Comments on the 2018 ESC Fourth Universal Definition of Myocardial Infarction”,1 we are prompted to comment on the diagnosis of type 4a acute myocardial infarction (AMI), ...

Among patients undergoing non-cardiac surgery more than 1 year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischaemic outcomes or major bleeding ...

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

ABSTRACT: Background: Coronary artery diseases (CAD) are one of the most important health problems in the world. The necessity of examining effective factors and exploring risk factors on CAD must be ...

Empagliflozin improves cardiovascular outcomes in patients with heart failure, patients with type 2 diabetes who are at high cardiovascular risk, and patients with chronic kidney disease. The safety ...